LUPIN2019-01-012019-03-31in-bse-fin:OneOperatingExpenses01Member LUPIN2019-01-012019-03-31in-bse-fin:FourOperatingExpenses01Member LUPIN2019-01-012019-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LUPIN2019-01-012019-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LUPIN2019-01-012019-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member LUPIN2019-01-012019-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares LUPIN 2018-04-01 2019-03-31 2019-04-26 INR Millions Yearly Single segment Pharmaceuticals 2019-01-01 2019-03-31 Audited Consolidated 43259300000.00 1668900000.00 44928200000.00 8686400000.00 5865400000.00 -473400000.00 7996000000.00 855200000.00 2807800000.00 13265900000.00 39003300000.00 5924900000.00 37200000.00 5962100000.00 3251900000.00 -253500000.00 2998400000.00 0.00 2963700000.00 0.00 0.00 0.00 0.00 2963700000.00 402200000.00 3365900000.00 2895600000.00 68100000.00 3297600000.00 68300000.00 905000000.00 2 6.35 6.33 6.40 6.37 12.75 12.70 2018-04-01 2019-03-31 Audited Consolidated 163693700000.00 7128300000.00 170822000000.00 35596700000.00 24595500000.00 -1734300000.00 31512900000.00 3078300000.00 10850100000.00 48388800000.00 152288000000.00 18534000000.00 -3362300000.00 15171700000.00 8727000000.00 289900000.00 9016900000.00 0.00 6154800000.00 0.00 0.00 0.00 0.00 6154800000.00 -2336900000.00 3817900000.00 6065500000.00 89300000.00 3721700000.00 96200000.00 905000000.00 2 136517300000.00 20.93 20.84 13.41 13.36 34.34 34.20 Other Expenses 13265900000.00 Other Expenses 48388800000.00 0.00 0.00 0.00